Lv7
3950 积分 2020-06-30 加入
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
4天前
已完结
Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study
8天前
已完结
Novel treatment options in rituximab-resistant membranous nephropathy patients
1个月前
已完结
Primary membranous nephropathy: an endless story
1个月前
已完结
Mapping antigens of membranous nephropathy: almost there
1个月前
已完结
Membranous nephropathy: Mechanistic insights and therapeutic perspectives
1个月前
已完结
TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
1个月前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
1个月前
已完结
Current drug treatment of myasthenia gravis
1个月前
已完结
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
1个月前
已完结
皖公网安备34019202002308
